newdrugapprovals.org
Lucentis rival one step away from NHS approval
Bayer’s Eylea (aflibercept), lucentis, novartis Aflibercept is a fusion protein approved in the United States for the treatment of wet macular degeneration and metastatic colorectal cancer. It is a…